BGI Genomics Co., Ltd. (SHE: 300676)

BGI Genomics Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Operating Revenue	4,138	4,333	7,036	6,754	8,387	2,794
Other Revenue	10.81	16.91	16.67	11.75	10.31	6.68
Revenue	4,149	4,350	7,053	6,766	8,397	2,800
Revenue Growth (YoY)	-30.42%	-38.33%	4.24%	-19.42%	199.86%	10.41%
Cost of Revenue	2,053	2,202	3,528	2,845	3,382	1,301
Gross Profit	2,097	2,147	3,526	3,921	5,015	1,500
Selling, General & Admin	1,373	1,441	1,998	1,637	1,630	827.42
Research & Development	509.92	523.23	526.46	474.79	611.32	306.15
Other Operating Expenses	25.9	4.1	-89	24.06	-10.23	8.94
Operating Expenses	2,026	2,035	2,620	2,241	2,372	1,242
Operating Income	70.32	112.94	905.27	1,680	2,643	257.59
Interest Expense	-85.33	-91.56	-100.76	-104.72	-89.04	-5.73
Interest & Investment Income	135.26	153.33	424.36	218.16	119.22	16.74
Currency Exchange Gain (Loss)	-24.95	-11.36	-2.27	-39.76	-138.51	5.2
Other Non Operating Income (Expenses)	-11.59	-6.44	-91.43	-4.04	-35.45	-4.26
EBT Excluding Unusual Items	83.71	156.91	1,135	1,750	2,499	269.53
Gain (Loss) on Sale of Investments	-16.64	-34.36	80.73	86.41	52.2	11.56
Gain (Loss) on Sale of Assets	3.59	2.76	0.11	-3.88	-4.23	2.69
Asset Writedown	-10.18	-9.25	-209.24	-102.24	-105.02	-1.2
Other Unusual Items	17.71	-0.53	0.02	15.87	0	45.6
Pretax Income	78.2	115.54	1,007	1,746	2,442	328.19
Income Tax Expense	14.33	21.85	197.51	268.19	340.24	49.67
Earnings From Continuing Operations	63.87	93.68	809.29	1,478	2,102	278.52
Minority Interest in Earnings	-2.56	-0.78	-6.52	-16.16	-11.77	-2.19
Net Income	61.31	92.9	802.77	1,462	2,090	276.33
Preferred Dividends & Other Adjustments	-	-	-	-	1.4	-
Net Income to Common	61.31	92.9	802.77	1,462	2,089	276.33
Net Income Growth	-75.14%	-88.43%	-45.07%	-30.08%	656.43%	-28.53%
Shares Outstanding (Basic)	415	410	410	410	398	400
Shares Outstanding (Diluted)	417	412	410	412	399	400
Shares Change (YoY)	1.54%	0.48%	-0.32%	3.11%	-0.20%	-0.00%
EPS (Basic)	0.15	0.23	1.96	3.56	5.25	0.69
EPS (Diluted)	0.15	0.23	1.96	3.55	5.24	0.69
EPS Growth	-75.52%	-88.48%	-44.90%	-32.25%	658.65%	-28.53%
Free Cash Flow	-583.97	-827.62	-1,136	2,093	3,302	-402.18
Free Cash Flow Per Share	-1.40	-2.01	-2.77	5.08	8.27	-1.01
Dividend Per Share	0.100	0.100	1.000	0.350	0.350	0.100
Dividend Growth	-90.00%	-90.00%	185.71%	0%	250.00%	-66.67%
Gross Margin	50.53%	49.37%	49.99%	57.95%	59.72%	53.56%
Operating Margin	1.69%	2.60%	12.83%	24.83%	31.48%	9.20%
Profit Margin	1.48%	2.14%	11.38%	21.60%	24.88%	9.87%
Free Cash Flow Margin	-14.07%	-19.03%	-16.10%	30.93%	39.32%	-14.36%
EBITDA	436.65	464.67	1,262	1,959	2,945	498.67
EBITDA Margin	10.52%	10.68%	17.90%	28.95%	35.08%	17.81%
D&A For EBITDA	366.32	351.73	357.13	278.78	302.33	241.08
EBIT	70.32	112.94	905.27	1,680	2,643	257.59
EBIT Margin	1.69%	2.60%	12.83%	24.83%	31.48%	9.20%
Effective Tax Rate	18.32%	18.92%	19.62%	15.36%	13.93%	15.13%
Revenue as Reported	4,149	4,350	7,053	6,766	-	2,800

Source: S&P Capital IQ. Standard template. Financial Sources.